Insulet Corporation (PODD)
After hours:
Chart Events
Performance Outlook
| Previous Close | 217.94 |
| Open | 217.18 |
| Bid | 225.00 x 800 |
| Ask | 227.72 x 900 |
| Day's Range | 216.27 - 226.70 |
| 52 Week Range | 181.00 - 324.81 |
| Volume | |
| Avg. Volume | 530,419 |
| Market Cap | 15.618B |
| Beta (5Y Monthly) | 0.66 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.44 |
| Earnings Date | Feb 21, 2022 - Feb 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 280.79 |
- Business Wire
Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
ACTON, Mass., June 30, 2022--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the second quarter of 2022 on August 4, 2022 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).
- InvestorPlace
7 Stocks to Buy That Could Make You a Millionaire
Recent declines on Wall Street have been unnerving for most investors. So far in the year the S&P 500 index has lost around 21%. But you can still find some interesting stocks to buy right now. Investing is a long-term strategy that helps many of us prepare for later years. Metrics suggest between 1991 and 2020, the average return for the S&P 500 index has been well over 10%. For instance, let’s assume you are now 35 with $10,000 in savings and you plan to retire at age 65. You decide to invest
- Simply Wall St.
Insulet (NASDAQ:PODD) shareholders are still up 307% over 5 years despite pulling back 9.2% in the past week
While Insulet Corporation ( NASDAQ:PODD ) shareholders are probably generally happy, the stock hasn't had particularly...
